METHODS	A quality-of-life-adjusted survival analysis ( Quality-Adjusted Time Without Symptoms , and Toxicity [ Q-TWiST ] ) was applied to the Eastern Cooperative Oncology Group Trial E1684 , which compared high-dose IFN alpha 2b treatment for 1 year versus observation in 280 high-risk patients .\